Year-end Sale % OFF 
Abstract
SummaryThe intensive arsenical therapy used in the 5-day treatment of syphilis produces no demonstrable effect on the bone marrow of patients who have no individual idiosyncrasy to arsenical drugs. Cases of primary and secondary syphilis in which there is no change in the peripheral blood picture have a distribution of cell types in the bone marrow which is within the normal limits of variation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
